Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002544
What this trial is testing

Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Arbeitsgemeinschaft fur Internistische Onkologie 300
Not applicableUnknownNCT03672084
What this trial is testing

Allo-HSCT as First-line Consolidation in High-risk PTCL

Who this might be right for
T Cell Lymphoma
Peking University People's Hospital 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04607421
What this trial is testing

Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Neoplasms
Pfizer 841
Large-scale testing (Phase 3)Study completedNCT01041404
What this trial is testing

ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 584
Testing effectiveness (Phase 2)UnknownNCT03614364
What this trial is testing

Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma

Who this might be right for
Salivary Duct Carcinoma
Samsung Medical Center 41
Not applicableUnknownNCT02055144
What this trial is testing

Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy

Who this might be right for
Non Small Cell Lung Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 100
Testing effectiveness (Phase 2)Study completedNCT01951586
What this trial is testing

Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Amgen 226
Large-scale testing (Phase 3)Looking for participantsNCT07165951
What this trial is testing

Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 566
Early research (Phase 1)WithdrawnNCT02661659
What this trial is testing

A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
University of Chicago
Testing effectiveness (Phase 2)Study completedNCT00222469
What this trial is testing

Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
University of Oklahoma 50
Not applicableStudy completedNCT07272265
What this trial is testing

The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 300
Large-scale testing (Phase 3)UnknownNCT02859077
What this trial is testing

EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

Who this might be right for
Non-Small-Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 100
Testing effectiveness (Phase 2)Ended earlyNCT01904253
What this trial is testing

Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy

Who this might be right for
Small Cell Lung Cancer (SCLC)
Taiho Oncology, Inc. 18
Large-scale testing (Phase 3)Study completedNCT03777657
What this trial is testing

Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma

Who this might be right for
Gastric, or Gastroesophageal Junction Adenocarcinoma
BeiGene 997
Large-scale testing (Phase 3)UnknownNCT02738346
What this trial is testing

SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013

Who this might be right for
Small Cell Lung Cancer
University Hospital, Angers 164
Testing effectiveness (Phase 2)UnknownNCT03990103
What this trial is testing

S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites

Who this might be right for
Metastatic Gastric Adenocarcinoma
China Medical University, China 66
Testing effectiveness (Phase 2)Study completedNCT00859469
What this trial is testing

Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

Who this might be right for
Mesothelioma
Columbia University 29
Large-scale testing (Phase 3)Ended earlyNCT04675983
What this trial is testing

Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)

Who this might be right for
Gastric Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT01417494
What this trial is testing

1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 102
Large-scale testing (Phase 3)Active Not RecruitingNCT04884360
What this trial is testing

D9319C00001- 1L OC Mono Global RCT

Who this might be right for
Ovarian Cancer
AstraZeneca 366
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation